U.S. Markets closed
  • S&P Futures

    3,433.75
    +11.00 (+0.32%)
     
  • Dow Futures

    28,198.00
    +98.00 (+0.35%)
     
  • Nasdaq Futures

    11,686.50
    +36.25 (+0.31%)
     
  • Russell 2000 Futures

    1,617.20
    +5.90 (+0.37%)
     
  • Crude Oil

    40.57
    -0.26 (-0.64%)
     
  • Gold

    1,906.20
    -5.50 (-0.29%)
     
  • Silver

    24.58
    -0.12 (-0.50%)
     
  • EUR/USD

    1.1773
    0.0000 (-0.0000%)
     
  • 10-Yr Bond

    0.7610
    +0.0170 (+2.28%)
     
  • Vix

    29.18
    +1.77 (+6.46%)
     
  • GBP/USD

    1.2946
    +0.0006 (+0.0427%)
     
  • USD/JPY

    105.5600
    +0.1300 (+0.1233%)
     
  • BTC-USD

    11,702.99
    +645.98 (+5.84%)
     
  • CMC Crypto 200

    238.34
    +4.67 (+2.00%)
     
  • FTSE 100

    5,884.65
    -34.93 (-0.59%)
     
  • Nikkei 225

    23,654.15
    -16.98 (-0.07%)
     

Global Parkinson's Disease Market and Competitive Landscape 2020 - ResearchAndMarkets.com

·4 mins read

The "Global Parkinson's Disease Market and Competitive Landscape 2020" report has been added to ResearchAndMarkets.com's offering.

This research report provides comprehensive insights into the Parkinson's Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. The research analyzes and forecasts the Parkinson's Disease market size and drug sales. It also provides insights into Parkinson's Disease epidemiology and late stage pipeline.

Research Scope

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global

  • Parkinson's Disease pipeline: Find out drugs in clinical trials for the treatment of Parkinson's Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company

  • Parkinson's Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Parkinson's Disease by countries

  • Parkinson's Disease drugs: Identify key drugs marketed and prescribed for Parkinson's Disease in the US, including trade name, molecule name, and company

  • Parkinson's Disease drugs sales: Find out the sales value for Parkinson's Disease drugs by countries

  • Parkinson's Disease market valuations: Find out the market size for Parkinson's Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024

  • Parkinson's Disease drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research

  • Evaluate commercial market opportunities for Parkinson's Disease drugs

  • Synthesize insights for business development & licensing

  • Track market size, competitor drug sales, market shares in the Parkinson's Disease market

  • Develop in-depth knowledge of competition and markets

  • Analyze Parkinson's Disease drug sales data to update your brand planning trackers

  • Develop tactics and strategies to take advantage of opportunities in the market

  • Track Market Events and Trends and analyze key events in the Parkinson's Disease market

  • Develop forecast models, healthcare frameworks, or economic models

  • Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered

1. Parkinson's Disease Treatment Options

2. Parkinson's Disease Pipeline Insights

2.1. Parkinson's Disease Phase 3 Clinical Trials

2.2. Parkinson's Disease Phase 2 Clinical Trials

2.3. Parkinson's Disease Phase 1 Clinical Trials

3. Parkinson's Disease Epidemiology Analysis by Countries

4. US Parkinson's Disease Market Insights

4.1. Marketed Drugs for Parkinson's Disease in US

4.2. US Parkinson's Disease Market Size & Forecast

4.3. US Parkinson's Disease Drugs Sales & Forecast

4.4. US Parkinson's Disease Market Share Analysis

5. Germany Parkinson's Disease Market Insights

5.1. Marketed Drugs for Parkinson's Disease in Germany

5.2. Germany Parkinson's Disease Market Size & Forecast

5.3. Germany Parkinson's Disease Drugs Sales Forecast

5.4. Germany Parkinson's Disease Market Share Analysis

6. France Parkinson's Disease Market Insights

6.1. Marketed Drugs for Parkinson's Disease in France

6.2. France Parkinson's Disease Market Size & Forecast

6.3. France Parkinson's Disease Product Sales Forecast

6.4. France Parkinson's Disease Market Share Analysis

7. Italy Parkinson's Disease Market Insights

7.1. Marketed Drugs for Parkinson's Disease in Italy

7.2. Italy Parkinson's Disease Market Size & Forecast

7.3. Italy Parkinson's Disease Product Sales Forecast

7.4. Italy Parkinson's Disease Market Share Analysis

8. Spain Parkinson's Disease Market Insights

8.1. Marketed Drugs for Parkinson's Disease in Spain

8.2. Spain Parkinson's Disease Market Size & Forecast

8.3. Spain Parkinson's Disease Product Sales Forecast

8.4. Spain Parkinson's Disease Market Share Analysis

9. UK Parkinson's Disease Market Insights

9.1. Marketed Drugs for Parkinson's Disease in UK

9.2. UK Parkinson's Disease Market Size & Forecast

9.3. UK Parkinson's Disease Product Sales Forecast

9.4. UK Parkinson's Disease Market Share Analysis

10. Europe Parkinson's Disease Market Insights

10.1. Europe Parkinson's Disease Market Size & Forecast

10.2. Europe Parkinson's Disease Product Sales Forecast

10.3. Europe Parkinson's Disease Market Share Analysis

11. Japan Parkinson's Disease Market Insights

11.1. Marketed Drugs for Parkinson's Disease in Japan

11.2. Japan Parkinson's Disease Market Size & Forecast

11.3. Japan Parkinson's Disease Product Sales Forecast

11.4. Japan Parkinson's Disease Market Share Analysis

12. Global Parkinson's Disease Market Insights

12.1. Global Parkinson's Disease Market Size & Forecast

12.2. Global Parkinson's Disease Product Sales Forecast

12.3. Global Parkinson's Disease Market Share Analysis

For more information about this report visit https://www.researchandmarkets.com/r/655qz2

View source version on businesswire.com: https://www.businesswire.com/news/home/20200511005668/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900